Objective to study the relationship between soluble tumor necrosis factor receptor (STNFR) 1, 2 and insulin resistance (IR).
目的了解血清可溶性肿瘤坏死因子受体(STNFR)1,2与胰岛素抵抗(IR)的关系。
Conclusions STNFR might inhibit the bioactivity of TNF and decrease the body immunity. STNFR may be as a parameter in evaluating the severity and prognosis of disease.
结论STNFR抑制了TNF生物学活性而降低了机体的免疫功能,并可作为评估病情严重程度和预后的指标。
In addition, the reduced risk of developing colorectal tumors associated with regularly taking aspirin or NSAIDs was primarily seen among participants with high baseline sTNFR-2 levels.
此外,定期服用阿司匹林或非甾体类抗炎药降低患结直肠肿瘤的风险主要是表现在那些stnfr—2基准水平较高的参与者身上。
In addition, the reduced risk of developing colorectal tumors associated with regularly taking aspirin or NSAIDs was primarily seen among participants with high baseline sTNFR-2 levels.
此外,定期服用阿司匹林或非甾体类抗炎药降低患结直肠肿瘤的风险主要是表现在那些stnfr—2基准水平较高的参与者身上。
应用推荐